Google Übersetzer
Kezar Life Sciences, Inc.
About
Kezar Life Sciences, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 12 2026
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
Jan 9 2026
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
Nov 12 2025
Kezar Life Sciences Reports Third Quarter 2025 Financial Results
Nov 7 2025
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
Oct 16 2025
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives